ATP2A2 and Huntington disease: As shown in Fig 2A, all the HD-affected patients and even all the pre-manifest subjects displayed a highly significant reduction in SERCA2 mRNA, ranging from p<0.01 and p<0.001, compared with the control mRNA levels.